Canagliflozin reduces CV events in patients with T2DM and prior CV events | AHA

Primary endpoint was composite of CV death, nonfatal myocardial infarction, or nonfatal stroke.
Primary endpoint was composite of CV death, nonfatal myocardial infarction, or nonfatal stroke.